Cervical screening during the COVID-19 pandemic: optimising recovery strategies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cervical screening during the COVID-19 pandemic: optimising recovery strategies
Authors
Keywords
-
Journal
Lancet Public Health
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-05-01
DOI
10.1016/s2468-2667(21)00078-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses
- (2021) Alejandra Castanon et al. BRITISH JOURNAL OF CANCER
- Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis
- (2021) Jane J. Kim et al. PLOS MEDICINE
- Impact of COVID-19-related care disruptions on cervical cancer screening in the United States
- (2021) Emily A Burger et al. JOURNAL OF MEDICAL SCREENING
- Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study
- (2021) Lucie de Jonge et al. Lancet Gastroenterology & Hepatology
- Self-Collection for Cervical Screening Programs: From Research to Reality
- (2020) David Hawkes et al. Cancers
- Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
- (2020) Elizabeth T. H. Fontham et al. CA-A CANCER JOURNAL FOR CLINICIANS
- European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic
- (2020) Andrea Ciavattini et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
- (2020) Camille Maringe et al. LANCET ONCOLOGY
- COVID-19 and cancer
- (2020) Norman E. Sharpless SCIENCE
- Adherence to international recommendations in the governance and organisation of Nordic cervical cancer screening programmes
- (2020) Veli-Matti Partanen et al. ACTA ONCOLOGICA
- HPV Vaccination and the Risk of Invasive Cervical Cancer
- (2020) Jiayao Lei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delay in Cancer Screening and Diagnosis During the COVID-19 Pandemic: What Is the Cost?
- (2020) Julie Vose ONCOLOGY-NEW YORK
- Could HPV testing on self-collected samples be routinely used in an organised cervical screening program? A modelled analysis
- (2020) Megan A Smith et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada
- (2020) Jean HE Yong et al. JOURNAL OF MEDICAL SCREENING
- Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States
- (2019) Jean-François Laprise et al. ANNALS OF INTERNAL MEDICINE
- Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programs
- (2018) Kate Cuschieri et al. INTERNATIONAL JOURNAL OF CANCER
- Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: A population-based case-control study
- (2018) Gudrun Broberg et al. PLoS One
- Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated women: a modelling study
- (2018) Talía Malagón et al. LANCET ONCOLOGY
- Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden
- (2017) Jiangrong Wang et al. PLOS MEDICINE
- Challenges in breast and cervical cancer control in Japan
- (2016) Catherine Sauvaget et al. LANCET ONCOLOGY
- Evaluating cytology for the detection of invasive cervical cancer
- (2015) R. Landy et al. CYTOPATHOLOGY
- Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
- (2014) K. M. Elfstrom et al. BMJ-British Medical Journal
- Perception of Cervical Cancer Screening Among Japanese University Students Who Have Never Had a Pap Smear: A Qualitative Study
- (2013) Sumiko Oshima et al. Asian Pacific Journal of Cancer Prevention
- Human Papillomavirus Infection and the Multistage Carcinogenesis of Cervical Cancer
- (2013) M. Schiffman et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
- (2013) Guglielmo Ronco et al. LANCET
- HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients
- (2012) F. Hinten et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening
- (2011) Dorien C. Rijkaart et al. INTERNATIONAL JOURNAL OF CANCER
- European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition--Summary Document
- (2010) M. Arbyn et al. ANNALS OF ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started